1. Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Issue 7 (22nd July 2019) Authors: Wieczorek, Grazyna; Bigaud, Marc; Pfister, Sabina; Ceci, Melanie; McMichael, Katriona; Afatsawo, Catherine; Hamburger, Meike; Texier, Celine; Henry, Maurane; Cojean, Celine; Erard, Marinette; Mamber, Nadja; Rush, James S Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 7(2019) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Issue 7 (22nd March 2019) Authors: Wieczorek, Grazyna; Bigaud, Marc; Pfister, Sabina; Ceci, Melanie; McMichael, Katriona; Afatsawo, Catherine; Hamburger, Meike; Texier, Celine; Henry, Maurane; Cojean, Celine; Erard, Marinette; Mamber, Nadja; Rush, James S Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 7(2019) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0174 SUBCUTANEOUS DOSING OF THE NOVEL ANTI-CD40 ANTIBODY ISCALIMAB ACHIEVES TARGET DRUG EXPOSURE AND CLINICAL EFFICACY IN PRIMARY SJÖGREN'S SYNDROME; RESULTS OF A PHASE IIA RANDOMISED OPEN LABEL TWO ARM PARALLEL GROUP TRIAL. (June 2019) Authors: Fisher, Benjamin; Szántó, Antónia; Ng, Wan Fai; Bombardieri, Michele; Posch, Maximilian; Papas, Athena; Farag, Arwa; Daikeler, Thomas; Bannert, Bettina; Kivitz, Alan; Carsons, Steven; Isenberg, David; Barone, Francesca; Bowman, Simon J.; Espie, Pascal; Wieczorek, Grazyna; Moulin, Pierre; Floch, D... Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study. Issue 10 (19th August 2022) Authors: Kimball, Alexa B.; Loesche, Christian; Prens, Errol P.; Bechara, Falk G.; Weisman, Jamie; Rozenberg, Izabela; Jarvis, Philip; Peters, Thomas; Roth, Lukas; Wieczorek, Grazyna; Kolbinger, Frank; Jemec, Gregor B. E. Journal: Experimental dermatology Issue: Volume 31:Issue 10(2022) Page Start: 1522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Requirement of Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor–Induced Arthritis, but Not Fcγ Receptor–Mediated Platelet Elimination, in Mice. Issue 6 (26th April 2020) Authors: Martin, Kea; Touil, Ratiba; Cvijetic, Grozdan; Israel, Laura; Kolb, Yeter; Sarret, Sophie; Valeaux, Stéphanie; Degl'Innocenti, Elena; Le Meur, Thomas; Caesar, Nadja; Bardet, Maureen; Beerli, Christian; Zerwes, Hans‐Guenter; Kovarik, Jiri; Beltz, Karen; Schlapbach, Achim; Quancard, Jean; Régnier, ... Journal: Arthritis & rheumatology Issue: Volume 72:Issue 6(2020) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation. Issue 3 (26th March 2020) Authors: Huppertz, Christine; Jäger, Benedikt; Wieczorek, Grazyna; Engelhard, Peggy; Oliver, Stephen J.; Bauernfeind, Franz-Georg; Littlewood-Evans, Amanda; Welte, Tobias; Hornung, Veit; Prasse, Antje Journal: European respiratory journal Issue: Volume 55:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗